Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8408585 | Computational and Structural Biotechnology Journal | 2017 | 5 Pages |
Abstract
These three reasons combined with evidence that the current summary diagram of the basal ganglia involvement in PD is imprecise at best, suggest that a re-orientation of the treatment strategies towards cortical, rather than striatal malfunction, is overdue.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Gordon W. Arbuthnott, Marianela Garcia-Munoz,